#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma Small for dates baby Anti-HLA antibody test positive Brain abscess Fallopian tube cancer Pleural mesothelioma Cerebral amyloid angiopathy Plasma cell myeloma refractory Myasthenia gravis Glycogen storage disease type V Hyperinsulinism Still's disease Brain injury Hypomagnesaemia Paraneoplastic neurological syndrome More trials…

    Learn about Rare Diseases

    Propionic acidaemia – Trials in Disease Pemphigus – Treatment Mucopolysaccharidosis I – Trials in Disease Systemic sclerosis pulmonary – Life with Disease Friedreich’s ataxia – Treatment Pemphigoid – Diagnostics Idiopathic inflammatory myopathy – Trials in Disease Glycogen storage disease type I – Life with Disease Focal segmental glomerulosclerosis – Life with Disease Mucous membrane pemphigoid – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Belantamab Mafodotin Aptamer-4Ft Lasn01 Ammonium Chloride Bp Arachis Hypogaea Extract Letetresgene Autoleucel Fosamprenavir Calcium Pioglitazone Dronedarone Orlistat OSIMERTINIB MESYLATE Metyrapone Bp Exenatide Betahistine Dihydrochloride BMS-986365 Ly4100511 Fulvestrant Labetalol Hydrochloride Iopamidol Cefazolin More therapies…

    Learn about Your Condition

    Bone marrow failure Huntington's disease Toxicity to various agents Scoliosis Hyperparathyroidism primary Cholangiosarcoma Diabetic retinal oedema Chondroplasty Deep vein thrombosis Agitation Thrombolysis Mitral valve prolapse Muscle strain Exfoliation glaucoma Oxygen therapy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Evaluating Morphine Effectiveness Based on Kidney Function in Patients with Sickle Cell Disease During Vaso-occlusive Crisis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Morphine Hydrochloride
    • Iohexol
    France

  • Study on Pravastatin for Pregnant Patients with Preeclampsia or Intrauterine Growth Restriction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pravastatin Sodium
    Spain

  • Study on Tacrolimus and Sirolimus for Kidney Transplant Patients at High Risk of Cytomegalovirus Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Valganciclovir
    • Methylprednisolone Sodium Succinate
    Spain

  • Study on the Effects of Acetylsalicylic Acid and Cytisine for High-Risk Patients in Preventing Lung Cancer and Reducing Inflammation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cytisine
    • Acetylsalicylic Acid
    Italy

  • Study on Brain Inflammation in Schizophrenia Patients Using 18F-DPA-714

    Recruiting

    4 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

  • Study of Sevuparin for Patients with Chronic Kidney Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • SEVUPARIN
    Italy
Previous Page
1 2 3 4 5 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!